Skip to content
Home/Companies/HealthTech/Gnosco

Gnosco

HealthTech·Sweden·Exited 2025·Held 7yr
Entry
2018
Hold
7yr
Exit
2025

Who owns Gnosco?

Gnosco was owned by Almi Invest through Almi Invest (Regional funds) (2009 vintage) from 2018 to 2025, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-18

Almi Invest
Investor
Almi Invest
Almi Invest (Regional funds) · 2009 · VC

Key facts

HQSweden
SectorHealthTech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2025

More from Almi Invest (Regional funds)

Other portfolio companies in the same fund.

Cellevate
Active
BiotechSweden· 2026
CubaseBio
Active
BiotechSweden· 2026
DAJE Prevent
Active
MedTechSweden· 2026
Permitify
Active
SaaSSweden· 2026
Radar Reticence
Active
SoftwareSweden· 2026
Rivus
Active
SoftwareSweden· 2026

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
agilon health
agilon health
Active
CD&RUS
Akrivia Health
Akrivia Health
Active
Future Planet CapitalUK
Track Gnosco

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Gnosco?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Gnosco.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue